$DVAX

Dynavax Technologies Corp.

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$10.8 -

Extented Hours

VOLUME

3,522,427

DAY RANGE

10.24 - 11.32

52 WEEK

7.26 - 21.39

Join Discuss about DVAX with like-minded investors

SA
@saeedte #StockTraders.NET
recently

$DVAX also nice daily for swing but I got shaken out last week

57 Replies 10 👍 9 🔥

profile
@Chano #StockTraders.NET
recently

$DVAX nuts, very close to daily resistance

84 Replies 11 👍 9 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Monday, September 13, 2021 Futures Up/Down % Last Dow 233.00 0.68% 34,724 S&P 500 27.25 0.61% 4,476 Nasdaq 80.50 0.52% 15,514 Stock futures are looking sharply higher, with the S&P trying to snap its longest losing streak since February (5-days currently) ahead of key economic data this week (CPI and retail sales). Stocks are recovering despite a handful of negative headlines this weekend including a WSJ article that House Dems are considering a 26.5% corporate tax rate from 21.5% with a 3% surtax on individual incomes over $3m, & increasing higher rate capital gains tax to 28.8% from 23.8%. Also this weekend, Sen. Joe Manchin said this weekend he would not vote for the $3.5 trillion budget bill, adding that there’s “no way” to meet the September 27 deadline. In Asian markets, The Nikkei Index gained 65 points to 30,447, the Shanghai Index rose 12 points to 3,715 and the Hang Seng Index dropped -392 points (1.5%) to settle at 25,813. In Europe, the German DAX is surging over 175 points (1.1%) to 15,785, while the FTSE 100 is up over 50 points to 7,075. Stocks slipped all last week as the S&P fell 1.7%, the Dow lost 2.15%, the Nasdaq shed 1.61% as the S&P 500 extended its losing streak to 5-days, the longest since the middle of February. The S&P 500 has rallied over 38% without a 5%+ pullback over the last 309 calendar days. With the European Central Bank offering only a partial tapering of its bond purchases last week, while boosting growth forecasts, investors are now looking at an autumn glide path for stocks based on a similar move by the Federal Reserve later this month. Markets will closely watch the CPI inflation reading after another rise in producer prices (PPI) late last week. Market Closing Prices Yesterday The S&P 500 Index dropped -34.70 points, or 0.77%, to 4,458.58 The Dow Jones Industrial Average fell -271.66 points, or 0.78%, to 34,607.72 The Nasdaq Composite dropped -132.76 points, or 0.87%, to 15,115.49 The Russell 2000 Index declined -21.58 points, or 0.96% to 2,227.55 Events Calendar for Today 2:00 PM ET Federal Budget for August Earnings Calendar: Earnings Before the Open: NSSC, SEAC Earnings After the Close: AVO, CSBR, EPM, ICMB, MTRX, ORCL, RFIL, VOLT Other Key Events: Barclay’s Financial Services Conference (virtual) 2021, 9/13-9/15 BMO Capital 2021 Real Estate Conference (virtual), 9/13-9/14 Citigroup 2021 Global Technology Conference (virtual), 9/13-9/15 Cowen 2nd Annual Health, Wellness & Beauty Summit (virtual), 9/13-9/14 Credit Suisse 34th Annual Basic Materials Conference (virtual), 9/13-9/14 Deutsche Bank 11th Annual Aircraft, Finance & Leasing Conference, 9/13-9/14, in NY JPMorgan Gaming, Lodging, Restaurant & Leisure Management Forum, 9/13-9/14 Piper Global Technology Conference (virtual), 9/13-9/14 Piper 2021 D.C. Bank Field Trip, 9/13-9/15 Wells Fargo 10th Annual Lease REIT Forum (virtual), 9/13 Macro Up/Down Last Nymex 0.96 70.68 Brent 0.86 73.78 Gold +0.90 1,788.50 EUR/USD -0.0033 1.1781 JPY/USD 0.18 110.12 10-Year Note -0.005 1.336% World News House Democrats expect to propose raising the corporate tax rate to 26.5% from 21% and imposing a 3-percentage-point surtax on individual income above $5 million, according to two House Democratic aides familiar with the plans, the WSJ reported. The tax increases would be part of the House Ways and Means Committee’s plans to pay for the party’s priorities in a fast-moving budget bill. Those items include an expanded child tax credit, a national paid-leave program and renewable-energy tax breaks. Joe Manchin said this weekend he would not vote for the $3.5 trillion budget bill, adding that there’s “no way” to meet the September 27 deadline set by House Speaker Nancy Pelosi. Manchin’s comments come as lawmakers work to approve the measure which would invest in climate policy and expand social programs North Korea carried out successful tests of a new long-range cruise missile over the weekend, state media said on Monday Sector News Breakdown Consumer Homebuilders R. Horton ($DHI) and Meritage $(MTH) still look like relative bargains according to Barron’s saying when it comes to builders, book value may no longer be the only metric to look at. DHI, MDC and MTH look historically cheap based on current price/earnings, noting Wall Street analysts see double-digit gains ahead Boston Beer ($SAM) shares tumbled this week after warning of decelerating had seltzer category, with Barron’s saying with the stock now worth less than half what it was at its peak, it might be time to take a look at shares. The stock now looks to have support near $500, around its June 2020 lows. If that level holds, buying the stock in the low $500s could turn out to be a smart bet Toyota Motor Corp ($TM) and Honda Motor Co ($HMC) on Saturday sharply criticized a proposal by Democrats in the U.S. House of Representatives to give union-made electric vehicles in the United States an additional $4,500 tax incentive. Leslie’s ($LESL) files to sell 13M shares of common stock for holders MGM Resorts ($MGM) upgraded to Outperform from Market Perform at Bernstein Nike ($NKE) downgraded to Neutral from Buy at BTIG Stanley Black & Decker ($SWK) announced that it has entered into a definitive agreement to acquire Excel Industries for $375 million in cash. Energy, Industrials and Materials Virgin Galactic ($SPCE) said this weekend that the flight window for Unity 23 will be pushed back to mid-October at the earliest after a third-party supplier flagged a potential manufacturing defect in a component of the flight control actuation system. It is not yet known if the defect is present in any of Virgin’s vehicles or any repair work will be needed. Kansas City Southern (KSU) said on Sunday it planned to accept Canadian Pacific Railway’s ($CP) $27.2 billion cash-and-stock acquisition offer as superior to its $29.6 billion deal to sell itself to Canadian National Railway ($CNI), according to Reuters. Canadian National now has until the end of Friday to submit a better offer or lose its deal with Kansas City Southern. Rocket Lab USA ($RKLB) mentioned cautiously in Barron’s saying after a strong run for shares, it’s time to think about taking some profits. Recent positive news has sent shares skyrocketing, leaving even the most bullish investors wondering that to do next Atlas Air Worldwide ($AAWW) subsidiary, Atlas Air completes five-year joint collective bargaining agreement for its Atlas Air and Southern Air pilots. Trane Technologies ($TT) signed an agreement to acquire Farrar Scientific, a leader in ultra-low temperature control for biopharmaceutical and other life science applications for $250M US Well Services ($USWS) said it received written notice from the Nasdaq on Sept 7 indicating it had failed to comply with the minimum closing bid price requirement rule and will therefore be de-listed Louisiana declared a state of emergency ahead of Tropical Storm Nicholas Financials Beijing wants to break up Alipay, the hugely popular payments app owned by Jack Ma’s Ant Group, and create a separate app for the company’s highly profitable loans business, the Financial Times reported on Sunday. The plan will also see Ant turn over the user data that underpins its lending decisions to a new credit scoring joint-venture, which will be partly state-owned, the newspaper reported TransUnion ($TRU) said it has agreed to buy information-services company Neustar Inc. for $3.1 billion in cash, a move that sets the consumer-credit reporting giant to diversify beyond its core business and put data to new uses. The Chicago-based company Monday said it is buying Neustar from a private investment group led by Golden Gate Capital https://on.mktw.net/3tBRVou SVB Financial Group ($SIVB) mentioned positively in Barron’s saying the bank stands out in the stodgy world of banking because of its unusual role as a leading lender to innovative tech start-ups. While some banks have struggled to grow their loan book over the past year, SVB had 8% QoQ growth in loan balances, reflecting strong activity in the tech and healthcare sectors KeyCorp (KEY) sold its $3.2B indirect retail auto loan portfolio to a vehicle managed by a subsidiary of Waterfall Asset Management, and will use capital generated by the sale to buy back some of its stock. Healthcare Dynavax ($DVAX) shares slide -16%; as the British government ends a COVID-19 vaccine supply deal with French vaccine maker Valneva SE, alleging a breach of obligations that Valneva denies. Valneva is developing its COVID-19 vaccine, VLA2001, combined with DVAX’s adjuvant or vaccine booster, CpG 1018 AbbVie ($ABBV) and REGENXBIO ($RGNX) form a strategic partnership combining eye care and gene therapy expertise- Companies will develop and commercialize RGX-314, an investigational gene therapy for wet age-related macular degeneration, diabetic retinopathy and other chronic retinal diseases- REGENXBIO to receive $370 million upfront payment Leap Therapeutics ($LPTX) said it will be presenting initial data from the first-line cohort of the DisTinGuish study, a Phase 2a clinical trial evaluating Leap’s anti-Dickkopf-1, or DKK1, antibody, DKN-01, in combination with tislelizumab, BeiGene’s anti-PD-1 antibody, and chemotherapy, in patients with gastric or gastroesophageal junction cancer, at the European Society for Medical Oncology, or ESMO, Congress, being held virtually on September 16-21 MiMedx Group (MDXG) shares fall -19% as reports Top-line Data from Two Late-Stage Musculoskeletal Trials. Top-line results from an interim analysis of the Phase 2B trial for KOA did not meet primary endpoints. Top-line results from Phase 3 Plantar Fasciitis trial did not meet its primary endpoints. Israel is considering a fourth round of coronavirus vaccines, Bloomberg News reported, citing an interview a health ministry official. mostly uses the vaccine made by Pfizer ($PFE) and BioNTech ($BNTX), but also uses Moderna ($MRNA) Hepion Pharmaceuticals ($HEPH) schedules conference call to review data from phase 2a ‘AMBITION’ clinical trial of CRV431 in NASH; it expects to release additional data from its Phase 2a ‘AMBITION’ NASH clinical trial before the market opens on Monday, September 13, 2021. Technology, Media & Telecom Cisco ($CSCO mentioned in Barron’s noting the company is meeting with analysts on Wednesday for the first time in four year and the session could make or break the shares. The networking giant’s sales suffered last year as companies cut information technology spending early in the pandemic. But the trend has reversed in Cisco’s favor ViacomCBS Inc ($VIAC) is revamping the operations of its Paramount Pictures movie and television production unit under a broader management shake-up, the Wall Street Journal reported on Sunday, citing people familiar with the matter. The realignment will see Paramount Television expected to focus primarily on making content for its sister cable and streaming networks Canon ($CAJ) announced that it has reached an agreement with Redlen Technologies to conclude a share transfer agreement, making Redlen a wholly owned subsidiary of Canon

127 Replies 7 👍 8 🔥

profile
@maletone #StockTraders.NET
recently

watchlist for tomorrow: $DLPN, $RIDE, $GAMB, $DVAX, $GSMG, $KXIN

66 Replies 15 👍 9 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Wednesday, August 4, 2021 Futures Up/Down % Last Dow -25.00 0.07% 34,973 S&P 500 -1.25 0.04% 4,413 Nasdaq 11.50 0.08% 15,058 U.S. S&P futures are flat heading into the trading day, looking to build on record highs from Tuesday as positive earnings boost U.S and European stocks while worries over China’s gaming and technology crackdown ease, helping lift those markets. Risk sentiment improves across Asia as Chinese and Hong Kong stocks push higher on tech recovery and solid Caixin PMI data. In Asian markets, The Nikkei Index fell -57 points to 27,854, the Shanghai Index rose 29 points to 3,477 and the Hang Seng Index jumped 231 points to settle at 26,426. In Europe, the German DAX is climbing around 125 points to 15,680, while the FTSE 100 is up 0.4% to 7,135. Chinese Jul Caixin Services PMI beat: 54.9 vs 50.6 consensus. Some also see the spread of the Covid-19 delta variant as delaying rather than stopping the economic recovery. The New York Times reported overnight that the FDA plans to give full approval to Pfizer (PFE) and BioNTech (BNTX) coronavirus vaccine by the start of the next month. Earnings season has been strong with about 87% of S&P 500 companies reporting earnings and revenue beats, according to FactSet. Just under 70% of the S&P 500 now has reported earnings. The S&P 500 closed at record highs with gains in Apple and healthcare stocks, as concerns over a surge in the Delta variant of the coronavirus was put to the back-burner, overshadowed by continued upbeat corporate earnings. Ten of the 11 S&P indexes traded higher, with energy stocks rebounding after getting hit by a dip in oil prices. Market Closing Prices Yesterday The S&P 500 Index gained 35.99 points, or 0.82%, to 4,423.15 The Dow Jones Industrial Average rose 278.24 points, or 0.80%, to 35,116.40 The Nasdaq Composite climbed 80.23 points, or 0.55%, to 14,761.29 The Russell 2000 Index advanced 8.09 points, or 0.36% to 2,223.58 Events Calendar for Today 7:00 AM ET MBA Mortgage Applications Data 8:15 AM ET ADP Employment Change for July…est. 695K 9:45 AM ET Markit Composite PMI, July-F 9:45 AM ET Markit Services PMI, July-F 10:00 AM ET ISM Non-Manufacturing Services PMI for July…est. 60.5 10:30 AM ET Weekly DOE Inventory Data Earnings Calendar: Earnings Before the Open: ABC, AEIS, ALE, APO, ASTE, BCOR, BDC, BGCP, BWA, CDW, CLVS, CLH, CLW, CMLS, CRL, CSII, DNOW, DOC, EDIT, EMR, ETR, EXC, FLOW, FUN, GEL, GM, HDSN, HFC, HZNP, IONS, JLL, KHC, LL, MAC, MKL, MPC, MPLX, MTOR, NI, NYT, ODP, RCL, SBGI, SGRY, SITE, SMG, SPR, SUP, TGI, TUP, TXMD, UTHR, VCEL, VMC, WLL Earnings After the Close: ACAD, ACLS, ADPT, ADTN, AGL, ALB, ALL, AMED, ANGI, ANSS, APA, ATO, AXGN, BBSI, BE, BFAM, BKNG, BOOT, CCMP, CDAY, CENX, CHNG, CMP, CPS, DGII, DOX, DVAX, DXC, EA, EGHT, ELF, EMKR, EOG, ETSY, EVH, FLT, FOXA, FSLY, FTDR, GDDY, GNK, HI, HUBS, IAC, INGN, IVR, JACK, LESL, LNC, LPI, LUMN, MAXR, MBI, MCK, MED, MET, MGM, MOD, MRO, MTG, NUS,NVRO, ONEM, PARR, PDCE, $PING, PLYA, QRVO, QTWO, RCII, REGI, RGR, RMAX, RNWK, EOKU, RPD, $RVLV, RYN, SBRA, SMSI, SUM, T$NDM, TPC, TTGT, TVTY, TWNK, TWO, TXG, $UBER, UHAL, VVV, VZIO, WDC, WU, YELL Other Key Events: Jefferies Industrials Conference (virtual), 8/3-8/4 Piper Wealth Management Forum (virtual), 8/3-8/6 Macro Up/Down Last Nymex -0.34 70.22 Brent -0.18 72.23 Gold 3.30 1,813.75 EUR/USD -0.0008 1.1856 JPY/USD 0.13 109.17 10-Year Note +0.008 1.182% Sector News Breakdown Consumer Caesar’s Entertainment ($CZR) Q2 EPS $0.34 vs. est. loss (-$0.26); Q2 revs $2.5B vs. est. $2.27B; Q2 same-store Adjusted EBITDA was $1B versus (-$131M) for the comparable prior-year period; Company posted all-time records in quarterly Adjusted EBITDA and Adjusted EBITDA margin. Denny’s ($DENN) Q2 adj EPS $0.18 vs. est. $0.11; Q2 revs $106.2M vs. est. $98.1M; Q2 domestic system-wide same-store sales decreased 1.2% compared to the equivalent fiscal period in 2019, including a 1.5% decrease at domestic franchised restaurants and a 1.9% increase at company restaurants. Herbalife ($HLF) Q2 adj EPS $1.52 vs. est. $1.29; Q2 revs $1.55B vs. est. $1.57B; Q2 adjusted EBITDA of $262.1M; raises FY21 EPS view to $4.70-$5.10 from $4.65-$5.05 (est. $4.93); sees FY net sales growth to be in a range of 8.5% to 12.5%, lowering the midpoint by 150 basis points compared to prior full year 2021 guidance. Host Hotels ($HST) Q2 adj FFO $0.12 vs. est. $0.04; Q2 revs $649M vs. est. $606.58M; said RevPAR reached nearly $100 for the quarter, which dramatically outperformed consensus RevPAR, with average room rates only 8.4% below our 2019 second quarter rates; not providing year guidance Hyatt ($H) 2Q adj EPS ($1.15) vs est. ($0.85) on comparable system-wide REVPAR $72.47, qtrly total revs $663Mm vs est. $686.9Mm; guides FY net rooms growth more than +6%, sees FY adj SG&A about $240Mm, sees FY CAPEX about $110Mm Energy Devon Energy ($DVN) Q2 adj EPS $0.60 vs est. $0.52 on revs $2.42B vs est. $2.35B, operating cash flow $1.1B, production for the quarter averaged 291k barrels/day; will pay total dividend of 49c/shr (11c fixed + 38c variable), a 44% increase from Q1; sees 3q production 566-594 mboe/d vs est. 564.80 mboe/d Occidental Petroleum ($OXY) Q2 adj EPS 32c vs est. 1c on revs $5.96B vs est. $5.92B, FCF $2B, cash flow from continuing operations $3.3B; said oil and gas results improved from Q1 due to higher commodity prices and sales volumes; executed debt tender offer and repaid over $3B of long-term debt in July ONEOK ($OKE) Q2 EPS $0.77 vs. est. $0.75; Q2 revs $3.39B vs. est. $3.03B; sees 2021 net income, adj earnings before interest, taxes, depreciation, amortization to be above midpoints of ranges provided on April 27, 2021 SunPower ($SPWR) Q2 adj EPS $0.06 vs. est. $0.04; Q2 revs $308.9M vs. est. $327.31M; guides Q3 revs $325M-$375M vs. est. $400.83M; sees Q3 GAAP net loss of $10 to $0 million and MW recognized of 125 MW to 150 MW; Q2 added 13,000 residential customers – residential bookings up 16 percent sequentially, 67 percent year-over-year (YoY) The American Petroleum Institute ($API) showed a draw of 879K barrels of oil for the latest week; gasoline inventories show a draw of 5.75M barrels, distillate inventories show a draw of 717K barrels and Cushing inventories show a build of 659K barrels W&T Offshore ($WTI) Q2 EPS $0.02 vs. est. $0.07; Q2 revs $132.8M vs. est. $122.38M; Q2 Production was 40,888 Boe/d or 3.7 MMBoe, an increase of 3% compared to 39,657 Boe/d in Q1 and down 3% versus 42,037 Boe/d in Q2 of 2020 Financials Assurant Inc. ($AIZ) Q2 operating EPS $2.99 vs. est. $2.45; Q2 revs $2.54B vs. est. $2.39B; continue to expect to grow eps, ex. catastrophes, by 10 to 14 percent for 2021 Fair Isaac ($FICO) Q3 non-GAAP EPS $3.38 vs. est. $2.76; Q3 revs $338M vs. est. $328.3M; Applications revenues, which include the company’s decision management applications and associated professional services, were $133.2 million in the third quarter, compared to $141.5 million in the prior year period, a decrease of 6% Genworth Financial ($GNW) Q2 adj EPS $0.38 vs. est. $0.22; Q2 revs $2.04B vs. est. $1.9B; planned IPO of Enact remains a key strategic objective for Genworth and is subject to market and other conditions, however because the company is in registration and subject to applicable publicity restrictions, is unable to comment further or provide any additional detail at this time. Green Dot ($GDOT) Q2 adj EPS $0.68 vs est. $0.43 on revs $369.4M vs est. $313.2M; sees FY21 adj EPS $2.13-$2.27 vs prev. $2.06-$2.15, revs $1.33B-$1.35B vs est. $1.28B Prudential ($PRU) Q2 adj EPS $3.79 vs. est. $3.02; qtrly book value per common share of $160.31 versus $165.53 per share for year-ago; qtrly adjusted book value per common share of $104.39 versus $92.07 per share for year-ago; qtr end assets under management of $1.730 trillion versus $1.605 trillion for year-ago; now expect to return a total of $11.0B to holders from $10.5B prior Tanger Outlets ($SKT) 2Q core FFO/shr $0.43 vs est. $0.28, portfolio occupancy was 93% on June 30 vs 91.7% on March 31, avg tenant sales productivity was $424/sq ft for 12 months ended June 30 +7.3% yr/yr; guides FY FFO/shr $1.52-1.59 vs est. $1.46 Unum Group (UNM) Q2 adj EPS $1.39 vs. est. $1.11; Q2 revs $2.99B vs. est. $2.96B; Full-year 2021 outlook increased; after-tax adjusted operating income per share now expected to decline 1%-3% relative to full-year 2020, compared to an expected decline of 5%-6% prior Verisk Analytics ($VRSK) Q2 adj EPS $1.17 vs. est. $1.33; Q2 revs $747.5M vs. est. $737.3M; Net cash provided by operating activities was $233.2 million, down 6.5% for the second quarter of 2021. Free cash flow, a non-GAAP measure, was $170.7 million, down 11.5% Healthcare Change Healthcare ($CHNG) shares fell over 7% on a report that the U.S. Dept. of Justice is considering a lawsuit to block the company’s $8B sale to UnitedHealth ($UNH) https://bit.ly/3yA4Etu Option Care Health ($OPCH) 18M share Spot Secondary priced at $20.25 Amgen Inc. ($AMGN) Q2 adj EPS $4.38 vs. est. $4.06; Q2 revs $6.5B vs. est. $6.43B; backs FY21 adj EPS view $16.00-$17.00 vs. est. $16.34; backs FY21 revenue view $25.8B-$26.6B vs. est. $26.04B Amid surge in new COVID-19 infections across U.S., the FDA plans to give full approval to Pfizer (PFE) – BioNTech (BNTX) coronavirus vaccine by the start of the next month, The New York Times reports The FDA classified the recent recall of some of Philips’ (PHG) ventilators as Class 1, or the most serious type of recall, saying the use of these devices may cause serious injuries or death – Reuters CVS Health ($CVS) Q2 adj EPS $2.42 vs. est. $2.06; Q2 revs $72.62B vs. est. $70.11B; raises FY21 adjusted EPS view to $7.70-$7.80 from $7.56-$7.68 (est. $7.66); sees FY21 cash flow from operations $12.5B-$13B DaVita Inc. (DVA) 2Q EPS $2.64 vs est. $2.17; says total US dialysis treatments for 2Q were 7,413497 (avg 95,045/day); guides FY adj EPS $8.80-9.40 vs est. $8.63, sees FY adj op income $1.8-1.875B vs est. $1.816B Inspire Medical ($INSP) 2Q EPS ($0.48) vs est. ($0.64) on revs $53Mm vs est. $43.9Mm; guides FY revs $210-213Mm vs est. $195.9Mm, sees FY gr mgn 85-86%, sees opening 48-52 new US medical centers per qtr for 2H Jazz Pharma ($JAZZ) Q2 adj EPS $3.90 vs. est. $3.42; Q2 revs $751.8M vs. est. $735.62M; reaffirms FY21 non-GAAP EPS view $13.40-$14.70 (est. $14.45) and also back FY21 revenue view $3.020B-$3.180B vs. est. $3.11B; as of June 30, cash, cash equivalents were $891.4 mln, and outstanding principal balance of co’s long-term debt was $7.1 bln

107 Replies 15 👍 10 🔥

profile
@achatzi #ivtrades
recently

$JMIA , $KND , $ZOM , $DVAX , $PLUG

97 Replies 9 👍 13 🔥

profile
@thegiz18 #ivtrades
recently

Lot of interesting earnings after close > @thegiz18 said: After close earnings today include $BYND, $ADSK, $BMRN, $CZR, $CVNA, $DELL, $DASH, $DVAX, $ETSY, $FTCH, $FSLR, $FSR, $GRPN, $HPQ, $NKLA, $QRTEA, $REGI, $RKT, $CRM, $SHAK, $STOR, $SFM, $RUN, $SPCE, $WDAY, $WW. $ZS that is a lot of stocks talked about on this group

132 Replies 11 👍 13 🔥

profile
@thegiz18 #ivtrades
recently

After close earnings today include $BYND, $ADSK, $BMRN, $CZR, $CVNA, $DELL, $DASH, $DVAX, $ETSY, $FTCH, $FSLR, $FSR, $GRPN, $HPQ, $NKLA, $QRTEA, $REGI, $RKT, $CRM, $SHAK, $STOR, $SFM, $RUN, $SPCE, $WDAY, $WW. $ZS that is a lot of stocks talked about on this group

128 Replies 6 👍 14 🔥

profile
@FUZZJP #ivtrades
recently

```Dynavax Technologies (NASDAQ: DVAX) and Valneva (OTCPK:INRLF) announce a commercial partnership for the supply of Dynavax's CpG 1018 adjuvant for use in Valneva's SARS-CoV-2 vaccine candidate, VLA2001.```

85 Replies 15 👍 6 🔥

profile
@Benlax #droscrew
recently

dvax is garbage

143 Replies 13 👍 12 🔥

TR
@TraderJack #ivtrades
recently

Yes, I had $NVAX since $13.5 and $DVAX since $6.00

98 Replies 12 👍 6 🔥

TR
@TraderJack #ivtrades
recently

Your guys can buy $AZN, $BMRN, $ALNY, $DVAX, $EBS, and $NBIX, these are the potential contractors for my vaccine. However, be careful that some of them will drop hard if they does not get my vaccine contracts...who will get the final deal is my insider information...secret..

66 Replies 15 👍 9 🔥

profile
@Benlax #droscrew
recently

fucking $DVAX

125 Replies 13 👍 8 🔥

TR
@TraderJack #ivtrades
recently

Everything related to vaccine go up a big....see my $NVAX and $DVAX. I need to speed up my own vaccine work...

123 Replies 15 👍 9 🔥

Key Metrics

Market Cap

1.36 B

Beta

0

Avg. Volume

4.55 M

Shares Outstanding

126.31 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-04

Next Dividend Date

Company Information

Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. The Company's commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], is approved in the U.S. for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Dynavax is also advancing CpG 1018 as a premier vaccine adjuvant through research collaborations and partnerships. Current collaborations are focused on adjuvanted vaccines for COVID-19, pertussis and universal influenza.

CEO: Ryan Spencer

Website:

HQ: 2100 Powell Street Emeryville, 94608 California

Related News